RxDoctor Payments DataLook up a doctor →

Sunil Babu, MD

Medical Oncology · Fort Wayne, INNPI 1891968301

Payments from drug & device makers

$12,534,635in general payments, 2019–2025

Across 2,879 payments — averaging $4353.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3.8M
  • E.r. Squibb & Sons, L.L.C.$1.6M
  • Acerta Pharma LLC$1.1M
  • Genentech, Inc.$1.1M
  • Janssen Research & Development, LLC$669K
  • Beigene, Ltd.$513K
  • plus $3.8M from 54 others
$43,892in research payments, 2019–2025

Across 18 payments — averaging $2438.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$30K
  • F. Hoffmann-la Roche AG$8K
  • Pfizer$4K
  • Radius Health, Inc.$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1,523$3,796,725
E.r. Squibb & Sons, L.L.C.126$1,571,404
Acerta Pharma LLC11$1,114,721
Genentech, Inc.109$1,080,340
Janssen Research & Development, LLC235$668,698
Beigene, Ltd.65$513,349
AstraZeneca(2 entities)123$468,307
Pfizer76$435,226
Novartis28$429,996
Eli Lilly19$366,489
Pharmaessentia USA Corporation38$360,854
Aadi Bioscience, Inc.8$279,263
Seagen Inc.46$234,716
Beone Medicines Ltd.28$224,971
Merck23$167,186
Ipsen Bioscience Inc.37$161,484
Radius Health, Inc.16$148,752
Regeneron38$101,788
TG Therapeutics, Inc.37$86,224
Halozyme Inc9$49,529
Stemline Therapeutics Inc.13$46,521
Amgen14$36,060
Astrazeneca UK Limited3$33,891
Takeda Pharmaceuticals U.S.A., Inc.13$24,050
Sanofi US Services Inc.5$22,090
Daiichi Sankyo Inc.10$14,698
Gilead(2 entities)29$14,226
Argenx US, Inc.23$12,813
Cornerstone Specialty Network LLC15$9,468
Helsinn Healthcare SA1$7,500
Beone Medicines USA, Inc.5$6,020
Janssen Scientific Affairs, LLC6$5,968
Johnson & Johnson(2 entities)16$5,578
Bayer5$4,968
Incyte Corporation8$4,584
Sanofi8$3,691
Pharmacosmos Therapeutics Inc.2$2,422
F. Hoffmann-la Roche AG6$2,398
AVEO Pharmaceuticals, Inc.5$2,291
Medivation LLC.2$2,158
Taiho Oncology, Inc.1$2,100
Beigene USA, Inc.12$1,953
Karyopharm Therapeutics Inc.6$1,907
GSK4$1,876
Caris MPI, Inc.2$1,023
Avyxa Pharma, LLC1$1,000
Fennec Pharmaceuticals, Inc.6$874
Boehringer Ingelheim1$520
Regeneron Healthcare Solutions, Inc.5$193
Bristol Myers Squibb4$180
Pharmacyclics LLC, An Abbvie Company10$170
Tempus AI, Inc3$148
Rigel Pharmaceuticals, Inc.2$143
Sobi, Inc2$143
Dova Pharmaceuticals2$126
Verastem, Inc.1$122
Foundation Medicine, Inc.1$98
ADC Therapeutics America, Inc.1$92
Astellas Pharma US Inc3$58
Jazz Pharmaceuticals Inc.3$58

How this compares

$12,534,635 in reported general payments places this provider in the 95th percentile of 67 medical oncology providers in Indiana.

See all medical oncology providers in Indiana →

Medicare billing

Part B allowed, 2024
$2,671,247
Medicare patients
514
Services billed
116,943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Fort Wayne

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →